These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13282450)

  • 21. Quantitative studies in diphtheria prophylaxis. Antigenic interactions. I. Simultaneous inoculations.
    BARNES JM; HOLT LB
    Br J Exp Pathol; 1955 Aug; 36(4):415-24. PubMed ID: 13250118
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe active cutaneous hypersensitivity in the rat produced by Hemophilus pertussis vaccine.
    ROWLEY DA; CHUTKOW J; ATTIG C
    J Exp Med; 1959 Nov; 110(5):751-69. PubMed ID: 14439721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the hemagglutinin of Bordetella pertussis. II. On the antigenicity of the Bordetella pertussis hemagglutinin].
    OGONUKI M; UEMATSU N
    Nihon Saikingaku Zasshi; 1961 May; 16():359-63. PubMed ID: 13730456
    [No Abstract]   [Full Text] [Related]  

  • 25. [Production and certain properties of pertussis endotoxin].
    CHISTOVICH GN; BOCHAGOVA DI; SAVEL'VOL'F GB
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):40-6. PubMed ID: 13282452
    [No Abstract]   [Full Text] [Related]  

  • 26. The separation of a protective antigen from a toxin-producing strain of Hemophilus pertussis.
    ROBBINS KC; PILLEMER L
    J Immunol; 1950 Oct; 65(4):393-406. PubMed ID: 14794902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Active immunization against Hemophilus pertussis: development of humeral antibodies in the rabbit. I].
    HILTBOLD B; HUBER L; REGAMEY RH
    Schweiz Z Pathol Bakteriol; 1957; 20(5):633-9. PubMed ID: 13495415
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on protection against experimental tularemia in mice. II. Immunogenicity of Bacterium tularense filtrates in mice and enhancement by Hemophilus pertussis vaccine.
    PANNELL L
    J Infect Dis; 1958; 102(2):167-73. PubMed ID: 13525776
    [No Abstract]   [Full Text] [Related]  

  • 29. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata.
    PILLEMER L
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):704-5. PubMed ID: 14808372
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on protection against experimental tularemia in mice. I. Altered susceptibility of white mice to tularemia following Hemophilus pertussis vaccination.
    PANNELL L
    J Infect Dis; 1958; 102(2):162-6. PubMed ID: 13525775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Production of pertussis-streptococcal anatoxin].
    BESPALOVA MV
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Sep; (9):58-61. PubMed ID: 13282456
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigenic Hemophilus pertussis vaccines grown on charcoal agar.
    ENSMINGER PW; CULBERTSON CG; POWELL HM
    J Infect Dis; 1953; 93(3):266-8. PubMed ID: 13109242
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. II. Effects of repeated pretreatments with crude toxin of Hemophilus pertussis and effects of anti-vaccine sera and the anti-crude sera on infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():301-8. PubMed ID: 13757277
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of crude toxin of Hemophilus pertussis and anti-crude toxin sera on infection with Hemophilus pertussis. I. Effects of pretreatment with crude toxin of Hemophilus pertussis and its anti-crude toxin sera on pulmonary infection with Hemophilus pertussis].
    KOBAYASHI K
    Paediatr Jpn; 1961; 65():293-300. PubMed ID: 13757276
    [No Abstract]   [Full Text] [Related]  

  • 35. Humoral antibodies and intradermal reactions to chemical fractions of Hemophilus parapertussis.
    SCHERP HW; BRADFORD WL; WIXOM E; DAY E; ALLEN RM
    AMA Am J Dis Child; 1954 Jun; 87(6):724-30. PubMed ID: 13157630
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm.
    MUNOZ J; RIBI E; LARSON CL
    J Immunol; 1959 Nov; 83():496-501. PubMed ID: 14425265
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification of Bordetella pertussis antigens using monoclonal antibodies.
    Larsen FS; Selmer JC; Hertz JB
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):271-7. PubMed ID: 6097091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemophilus pertussis soluble antigen and complement fixing antibodies.
    PARFENTJEV IA; VIRION ME
    J Immunol; 1948 Sep; 60(1):167-71. PubMed ID: 18881078
    [No Abstract]   [Full Text] [Related]  

  • 39. [Note on a hemosensitizing antigen isolated from Bordetella pertussis].
    BARBER C; SOARE I; WEINBACH R
    Rev Sci Med; 1961; 6():7-12. PubMed ID: 13864828
    [No Abstract]   [Full Text] [Related]  

  • 40. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.